Hypersensitivity to oxaliplatin: clinical features and risk factors. - Wikidata - wikimedia - TriplyDB

Hypersensitivity to oxaliplatin: clinical features and risk factors.

Hypersensitivity to oxaliplatin: clinical features and risk factors.

http://www.wikidata.org/entity/Q37497459

about

Comparison between hypersensitivity reactions to cycles of modified FOLFOX6 and XELOX therapies in patients with colorectal cancer An albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo.A single-arm Phase II validation study of preventing oxaliplatin-induced hypersensitivity reactions by dexamethasone: the AVOID trial.Diagnostic tools for hypersensitivity to platinum drugs and taxanes: skin testing, specific IgE, and mast cell/basophil mediators.Oxaliplatin-induced hypersensitivity reaction: underlying mechanisms and management.Hypersensitivity reactions associated with oxaliplatin and their clinical management.Platinum hypersensitivity and desensitization.Presentation and Diagnosis of Hypersensitivity to Platinum Drugs.State of the art in non-animal approaches for skin sensitization testing: from individual test methods towards testing strategies.Atypical presentation of fever as hypersensitivity reaction to oxaliplatin.

P2860

Q33600062-D7F4B424-EAC1-4D68-AC49-735B6AD9C70E Q33615268-937D7BFB-E201-461E-AF17-05DB35F4D8E0 Q36288948-BE19C07C-7040-485D-BED2-472C9B5FD624 Q38222050-2B53EE28-CAF1-4509-9BA4-C992B56B6011 Q38237316-FB8482A3-7818-43BB-A9CB-20E03B54DBA2 Q38259295-1E5D783A-B88E-460F-BB74-BD83BDAD9E85 Q38521636-8D688FF0-E8E6-4B9E-A3DA-DD820DD884AE Q38541188-7682D29A-4AA8-4FC6-89E6-1F2EDA1001B3 Q38746275-FAB14CB0-62F1-4CAD-9609-59431CF6FB37 Q40184667-5FEF798D-607B-40F5-834C-57E9219A0395

P2860

Hypersensitivity to oxaliplatin: clinical features and risk factors.

http://www.wikidata.org/entity/Q37497459

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Hypersensitivity to oxaliplatin: clinical features and risk factors.

@en

Hypersensitivity to oxaliplatin: clinical features and risk factors.

@nl

type

label

Hypersensitivity to oxaliplatin: clinical features and risk factors.

@en

Hypersensitivity to oxaliplatin: clinical features and risk factors.

@nl

prefLabel

Hypersensitivity to oxaliplatin: clinical features and risk factors.

@en

Hypersensitivity to oxaliplatin: clinical features and risk factors.

@nl

P1433

Q37497459-271F0FC4-3E85-4444-BD21-DE88E3B72A4E

P1476

Q37497459-D772F034-5144-4B88-AB1F-CF2690D9B39C

P2093

Q37497459-029060FC-7B50-4A95-85BF-04F221A090CE

Q37497459-0D5C823E-4745-48F9-8A8B-CA8791CE93DA

Q37497459-1EC7C360-118C-4C8C-A668-FE42A768B4F8

Q37497459-4F8BE46D-3171-42D3-987C-4EF5B4CF148D

Q37497459-4FD18785-A8A8-4254-8C95-9E5F3FB7636F

Q37497459-6774DE9F-4604-4AFC-8084-CECEF9318BFD

Q37497459-8B9D02CC-1312-431E-923F-8DADB7EB105D

Q37497459-94F117DC-27A0-4F3C-9BA9-2D38A77AE213

Q37497459-AEA44F48-3623-4991-8737-253E8309D294

Q37497459-B65466C3-E7AC-4E9D-928B-B4E079184470

P2860

Q37497459-059CDA47-09E5-48C8-9613-02C0FEBCF095

Q37497459-060BCA63-6490-462E-BF65-5B9B09361EB5

Q37497459-1A129764-3A35-4A88-A409-465A2690AAB6

Q37497459-23BB0697-6CA4-4E48-A8B3-8BE4A118472D

Q37497459-2545DC90-B361-408B-87ED-29ADAF97E0FB

Q37497459-3F1C27EF-103F-424B-868E-23986054DCE0

Q37497459-5D71ACB5-4141-4E58-A1C0-8C3FC93C3896

Q37497459-64257308-75D8-4A31-813E-B11AB9B4E76F

Q37497459-7ABB30D1-9D90-49BF-A242-3F34777F1D7A

Q37497459-7AC272AC-8137-41CA-AE12-A3CA686CDB3C

P2888

Q37497459-066ABF5B-F6A1-4E6A-A007-5821503E4A30

P304

Q37497459-9F4104EC-1356-4386-8FB4-8803E64847C1

P31

Q37497459-D18F6D94-9DDC-462D-84AF-E05510E6B7E3

P356

Q37497459-45856E2C-A36C-4944-A8A0-2F6218DF4AD8

P478

Q37497459-9E349330-A300-4551-AACC-431041173E42

P50

Q37497459-1B0FFB53-8EE2-4242-A548-333AFC1EF25C

Q37497459-2F7EC3EA-83BF-42F8-B924-371EB85A920C

Q37497459-DD67B8D4-BA1E-4294-B924-B01246BD4E7C

P577

Q37497459-82F4952D-FDA9-4375-9DFE-2B1874333049

P5875

Q37497459-E121B58D-C516-445E-AF12-4AFC5E6A44DA

P6179

Q37497459-8762596D-D213-4E4C-A7C0-3574B45B02AA

P698

Q37497459-22A5D0A1-D816-4A9E-8585-A8C57BDAB1B7

P932

Q37497459-A78E0A7F-7E44-4E6D-ADB4-DAB7A4266B5D

P356

P1433

BMC pharmacology & toxicology

P1476

Hypersensitivity to oxaliplatin: clinical features and risk factors

@en

P2093

Benoit You

http://www.w3.org/2001/XMLSchema#string

Catherine Rioufol

http://www.w3.org/2001/XMLSchema#string

Chloé Gourc

http://www.w3.org/2001/XMLSchema#string

Céline Alloux

http://www.w3.org/2001/XMLSchema#string

Eléna Kiouris

http://www.w3.org/2001/XMLSchema#string

Florence Ranchon

http://www.w3.org/2001/XMLSchema#string

Gilles Freyer

http://www.w3.org/2001/XMLSchema#string

Marie Parel

http://www.w3.org/2001/XMLSchema#string

Marie-Gabrielle Guedat

http://www.w3.org/2001/XMLSchema#string

Nicolas Vantard

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience.

Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group.

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer.

Ethics and observational studies in medical research: various rules in a common framework.

Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review.

Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003.

Risk factors for oxaliplatin-induced hypersensitivity reactions in Japanese patients with advanced colorectal cancer

Hypersensitivity reactions to chemotherapeutic drugs.

A review of oxaliplatin and its clinical use in colorectal cancer.

Hypersensitivity reactions related to oxaliplatin (OHP).

P2888

P304

1

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/2050-6511-15-1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

frederic BERARD

P577

2014-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259719229

http://www.w3.org/2001/XMLSchema#string

P6179

1029123532

http://www.w3.org/2001/XMLSchema#string

P698

24417770

http://www.w3.org/2001/XMLSchema#string

P932

3896838

http://www.w3.org/2001/XMLSchema#string